Overview

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Administration of esomeprazole 20 mg to subjects who still had heartburn after receiving rabeprazole 10 mg once daily for at least 4 weeks will result in statistically significant improvement of heartburn after 8-week treatment.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Esomeprazole
Rabeprazole